Literature DB >> 9861033

The V domain of herpesvirus Ig-like receptor (HIgR) contains a major functional region in herpes simplex virus-1 entry into cells and interacts physically with the viral glycoprotein D.

F Cocchi1, M Lopez, L Menotti, M Aoubala, P Dubreuil, G Campadelli-Fiume.   

Abstract

The herpesvirus entry mediator C (HveC), previously known as poliovirus receptor-related protein 1 (PRR1), and the herpesvirus Ig-like receptor (HIgR) are the bona fide receptors employed by herpes simplex virus-1 and -2 (HSV-1 and -2) for entry into the human cell lines most frequently used in HSV studies. They share an identical ectodomain made of one V and two C2 domains and differ in transmembrane and cytoplasmic regions. Expression of their mRNA in the human nervous system suggests possible usage of these receptors in humans in the path of neuron infection by HSV. Glycoprotein D (gD) is the virion component that mediates HSV-1 entry into cells by interaction with cellular receptors. We report on the identification of the V domain of HIgR/PRR1 as a major functional region in HSV-1 entry by several approaches. First, the epitope recognized by mAb R1. 302 to HIgR/PRR1, capable of inhibiting infection, was mapped to the V domain. Second, a soluble form of HIgR/PRR1 consisting of the single V domain competed with cell-bound full-length receptor and blocked virion infectivity. Third, the V domain was sufficient to mediate HSV entry, as an engineered form of PRR1 in which the two C2 domains were deleted and the V domain was retained and fused to its transmembrane and cytoplasmic regions was still able to confer susceptibility, although at reduced efficiency relative to full-length receptor. Consistently, transfer of the V domain of HIgR/PRR1 to a functionally inactive structural homologue generated a chimeric receptor with virus-entry activity. Finally, the single V domain was sufficient for in vitro physical interaction with gD. The in vitro binding was specific as it was competed both by antibodies to the receptor and by a mAb to gD with potent neutralizing activity for HSV-1 infectivity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9861033      PMCID: PMC28107          DOI: 10.1073/pnas.95.26.15700

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Penetration of cells by herpes simplex virus does not require a low pH-dependent endocytic pathway.

Authors:  M Wittels; P G Spear
Journal:  Virus Res       Date:  1991-03       Impact factor: 3.303

2.  Functional domains of the poliovirus receptor.

Authors:  S Koike; I Ise; A Nomoto
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

3.  Single amino acid substitutions in gD of herpes simplex virus 1 confer resistance to gD-mediated interference and cause cell-type-dependent alterations in infectivity.

Authors:  H J Dean; S S Terhune; M T Shieh; N Susmarski; P G Spear
Journal:  Virology       Date:  1994-02-15       Impact factor: 3.616

4.  Glycoprotein D of herpes simplex virus encodes a domain which precludes penetration of cells expressing the glycoprotein by superinfecting herpes simplex virus.

Authors:  G Campadelli-Fiume; S Qi; E Avitabile; L Foà-Tomasi; R Brandimarti; B Roizman
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

5.  Glycosylphosphatidylinositol-anchored CD4/Thy-1 chimeric molecules serve as human immunodeficiency virus receptors in human, but not mouse, cells and are modulated by gangliosides.

Authors:  M Jasin; K A Page; D R Littman
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

6.  Mapping of herpes simplex virus 1 genes with mutations which overcome host restrictions to infection.

Authors:  R Brandimarti; T Huang; B Roizman; G Campadelli-Fiume
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

7.  Biochemical characterization and analysis of the transforming potential of the FLT3/FLK2 receptor tyrosine kinase.

Authors:  N Maroc; R Rottapel; O Rosnet; S Marchetto; C Lavezzi; P Mannoni; D Birnbaum; P Dubreuil
Journal:  Oncogene       Date:  1993-04       Impact factor: 9.867

8.  A mutant herpes simplex virus type 1 unable to express glycoprotein L cannot enter cells, and its particles lack glycoprotein H.

Authors:  C Roop; L Hutchinson; D C Johnson
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

9.  Construction and properties of a mutant of herpes simplex virus type 1 with glycoprotein H coding sequences deleted.

Authors:  A Forrester; H Farrell; G Wilkinson; J Kaye; N Davis-Poynter; T Minson
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

10.  CTLA-4 is a second receptor for the B cell activation antigen B7.

Authors:  P S Linsley; W Brady; M Urnes; L S Grosmaire; N K Damle; J A Ledbetter
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

View more
  53 in total

1.  Distinct cellular receptor interactions in poliovirus and rhinoviruses.

Authors:  L Xing; K Tjarnlund; B Lindqvist; G G Kaplan; D Feigelstock; R H Cheng; J M Casasnovas
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

Review 2.  Molecular pathways in virus-induced cytokine production.

Authors:  T H Mogensen; S R Paludan
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

3.  Localization of the gD-binding region of the human herpes simplex virus receptor, HveA.

Authors:  J C Whitbeck; S A Connolly; S H Willis; W Hou; C Krummenacher; M Ponce de Leon; H Lou; I Baribaud; R J Eisenberg; G H Cohen
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

4.  Effects of herpes simplex virus on structure and function of nectin-1/HveC.

Authors:  Claude Krummenacher; Isabelle Baribaud; James F Sanzo; Gary H Cohen; Roselyn J Eisenberg
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

5.  Structural features of nectin-2 (HveB) required for herpes simplex virus entry.

Authors:  W M Martinez; P G Spear
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

6.  Role of nectin in formation of E-cadherin-based adherens junctions in keratinocytes: analysis with the N-cadherin dominant negative mutant.

Authors:  Yoshinari Tanaka; Hiroyuki Nakanishi; Shigeki Kakunaga; Noriko Okabe; Tomomi Kawakatsu; Kazuya Shimizu; Yoshimi Takai
Journal:  Mol Biol Cell       Date:  2003-04       Impact factor: 4.138

7.  Novel, soluble isoform of the herpes simplex virus (HSV) receptor nectin1 (or PRR1-HIgR-HveC) modulates positively and negatively susceptibility to HSV infection.

Authors:  M Lopez; F Cocchi; E Avitabile; A Leclerc; J Adelaide; G Campadelli-Fiume; P Dubreuil
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

Review 8.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

9.  Striking similarity of murine nectin-1alpha to human nectin-1alpha (HveC) in sequence and activity as a glycoprotein D receptor for alphaherpesvirus entry.

Authors:  D Shukla; M C Dal Canto; C L Rowe; P G Spear
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

10.  Cellular localization of nectin-1 and glycoprotein D during herpes simplex virus infection.

Authors:  Claude Krummenacher; Isabelle Baribaud; Roselyn J Eisenberg; Gary H Cohen
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.